Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
Share Market News
Pro Medicus shares surge 10% to crack $300 as healthcare leads ASX 200 sectors
How to invest
Why $5,000 invested this way could grow substantially
Healthcare Shares
These healthcare stocks could be set to double according to broker
Broker Notes
10 Aussie stocks to buy in FY 2026
Broker Notes
5 ASX 200 shares for smart investors to buy in July
Blue Chip Shares
5 ASX 200 blue chip shares to buy in FY26 with $5,000
Growth Shares
Where to invest $50,000 in ASX shares
Share Gainers
Here are the top 10 ASX 200 shares today
Healthcare Shares
3 ASX companies that are global leaders
Share Gainers
Here are the top 10 ASX 200 shares today
Growth Shares
Where to invest $5,000 in ASX shares for growth
Share Gainers
Why Beach Energy, Boss Energy, Cochlear, and Light & Wonder shares are pushing higher
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
